Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcomaMary Cianfrocca, Joseph A. Sparano, David M. Aboulafia et al.|Cancer|2010Cited by 171
Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi’s Sarcoma: A Phase I AIDS Malignancy Consortium StudyMary Cianfrocca, Bruce J. Dezube, Timothy P. Cooley et al.|Journal of Clinical Oncology|2002Cited by 46
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trialMary Cianfrocca, Joseph A. Sparano, Jamie Von Roenn et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 22
M a t r i x M e t a l l o p r oteinase I nhibitor C OL-3 i n t he Treatment o f A IDS-Related K aposi's S arcoma: A P hase I AIDS M alignancy C onsortium S tudyMary Cianfrocca, Bruce J. Dezube, William D. Figg et al.|Unknown|2002Cited by 0